Table 1 Endometrial gene expression reports performed at the time of implantation in human using DNA microarray
Study | First sample (day of cycle, number of samples) | Second sample (day of cycle, number of samples) | Microarrays platform | Fold-change cut-off value | N° of up-regulated transcripts | N° of down-regulated transcripts |
|---|---|---|---|---|---|---|
Kao et al. (2002) [11] | Proliferative phase (8-11, n = 4) | Mid-secretory (21-23, n = 7) | Affymetrix Hu95A | ≥2.0 | 156 | 377 |
Carson et al. (2002) [13] | Early-secretory (15-17, n = 3*) | Mid-secretory (20-22, n = 3*) | Affymetrix Hu95A | ≥2.0 | 323 | 370 |
Borthwick et al. (2003) [12] | Proliferative phase (9-11, n = 5*) | Mid-secretory (19-21, n = 5*) | Affymetrix Hu95A-E | ≥2.0 | 90 | 46 |
Riesewijk et al. (2003) [14] | Early-secretory (15, n = 5) | Mid-secretory (20, n = 5) | Affymetrix Hu95A | ≥3.0 | 153 | 58 |
Mirkin et al. (2005) [15] | Early-secretory (16, n = 3) | Mid-secretory (21, n = 5) | Affymetrix HG_U95Av2 | ≥2.0 | 49 | 58 |
Talbi et al. (2006)¶ [9] | Early-secretory (n = 3) | Mid-secretory (n = 8) | Affymetrix HG-U133 plus 2.0 | ≥1.5 | 1415 | 1463 |
Haouzi et al. (2009)†[18] | Early-secretory (16, n = 31) | Mid-secretory (20, n = 31) | Affymetrix HG-U133 plus 2.0 | ≥2.0 | 945 | 67 |